-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IlUKblQWar4ZdLQqJ9Wk1i17x2smhu+Wy4j9ZiDvgALTDoHu56m5EjxMRD+o3EUc PFtESe5Hs3xjpNQknOgl9Q== 0001230295-08-000013.txt : 20080109 0001230295-08-000013.hdr.sgml : 20080109 20080109173357 ACCESSION NUMBER: 0001230295-08-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080107 FILED AS OF DATE: 20080109 DATE AS OF CHANGE: 20080109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YACHMETZ PHILIP K CENTRAL INDEX KEY: 0001250318 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 08521509 MAIL ADDRESS: STREET 1: 501 LAFAYETTE AVE CITY: WYCKOFF STATE: NJ ZIP: 07481 4 1 yac296.xml X0202 4 2008-01-07 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001250318 YACHMETZ PHILIP K C/O SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER BLVD., 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 EVP, Chief Business Officer Common Stock, $.01 par value per share 2008-01-07 4 M 0 1250 2.4200 A 144337 D Common Stock, $.01 par value per share 2008-01-07 4 M 0 3750 2.7800 A 148087 D Common Stock, $.01 par value per share 2008-01-07 4 S 0 5000 23.0211 D 143087 D Common Stock, $.01 par value per share 2008-01-08 4 M 0 5000 2.4200 A 148087 D Common Stock, $.01 par value per share 2008-01-08 4 S 0 5000 23.1519 D 143087 D Option to Purchase Common Stock, $.01 par value 2.4200 2008-01-07 4 M 0 1250 2.4200 D 2005-05-28 2014-05-28 Common Stock, $.01 par value per share 1250 77500 D Option to Purchase Common Stock, $.01 par value 2.7800 2008-01-07 4 M 0 3750 2.7800 D 2006-04-12 2015-04-12 Common Stock, $.01 par value per share 3750 12500 D Option to Purchase Common Stock, $.01 par value 2.4200 2008-01-08 4 M 0 5000 2.4200 D 2005-05-28 2014-05-28 Common Stock, $.01 par value per share 5000 72500 D This sale was made pursuant to a trading plan adopted on June 14, 2007 by the reporting person in accordance with Rule 105b-1 under the Securities Exchange Act of 1934. Represents the average sale price. The highest price at which shares were sold was $23.3401 and the lowest price at which shares were sold was $22.5601. Represents the average sale price. The highest price at which shares were sold was $23.43 and the lowest price at which shares were sold was $22.93 By: /s/ Irina Azer as Attorney-In-Fact for 2008-01-09 -----END PRIVACY-ENHANCED MESSAGE-----